1. World Health Organization (WHO). Surveillance of health care-associated infections at national and facility levels: practical handbook. Geneva: WHO; 2024.
2. Torriani F, Taplitz R. History of infection prevention and control. Infectious Diseases. 2010:76–85. doi: 10.1016/B978-0-323-04579-7.00006-X
3. Centers for Disease Control and Prevention (CDC). NHSN Patient Safety Component Manual, 2024. https://www.cdc.gov/nhsn/pdfs/validation/2024/pcsmanual_2024.pdf (erişim tarihi, 28
Ekim 2025)
4. Best M, Neuhauser D. Ignaz Semmelweis and the birth of infection control. Qual Saf Health Care. 2004;13(3):233-4.
5. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985;121(2):182-205.
6. Kubde D, Badge AK, Ugemuge S, Shahu S. Importance of Hospital Infection Control. Cureus. 2023 ;15(12):e50931. doi: 10.7759/cureus.50931
7. Ahuja S, Peiffer-Smadja N, Peven K, et al. Use of Feedback Data to Reduce Surgical Site Infections and Optimize Antibiotic Use in Surgery: A Systematic Scoping Review. Ann Surg. 2022
;275(2):e345-e352. doi: 10.1097/SLA.0000000000004909
8. Sickbert-Bennett EE, DiBiase LM. Infectious disease surveillance in healthcare settings. In: Weber DJ, Talbot TR, eds. Mayhall’s Hospital Epidemiology and Infection Prevention. 5th ed.
Philadelphia: Wolters Kluwer; 2020:73–89.
9. Suh KN, Lee TB. Chapter 4: Surveillance for Healthcare Infections. In: Friedman C, ed IFIC Basic Concepts of Infection Control. 3rd ed. Portadown, N Ireland, UK;International Federation
of Infection Control; 2016:1-17.
10. European Centre for Disease Prevention and Control (ECDC). Healthcare-associated infections surveillance network (HAI-Net). https://www.ecdc.europa.eu/en/about-us/partners-
hips-and-networks/disease-and-laboratory-networks/hai-net (erişim tarihi, 13 Ekim 2025)
11. TC Sağlık Bakanlığı. Yataklı Tedavi Kurumları Enfeksiyon Kontrol Yönetmeliği, Resmî Gazete, 11 Ağustos 2005; Sayı:25903. https://www.resmigazete.gov.tr/eskiler/2005/08/20050811-6.htm
12. TC Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü Bulaşıcı Hastalıklar ve Erken Uyarı Dairesi Başkanlığı. Ulusal Sağlık Hizmeti İle İlişkili Enfeksiyonlar Sürveyans Tanı Rehberi, 2024. ht-
tps://hsgm.saglik.gov.tr/depo/birimler/bulasici-hastaliklar-ve-erken-uyari-db/Dokumanlar/Rehberler/Ulusal_Saglik_Hizmeti_ile_Iliskili_Enfeksiyonlar_Surveyans_Tani_Rehberi_2024.pdf
(erişim tarihi, 27 Ekim 2025)
13. European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2022–2023.
Stockholm: ECDC; 2024. https://www.ecdc.europa.eu/en/publications-data/PPS-HAI-AMR-acute-care-europe-2022-2023 (erişim tarihi, 30 Eylül 2025)
14. Suetens C, Latour K, Kärki T,et al. Healthcare-Associated Infections Prevalence Study Group. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial
resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill. 2018 ;23(46):1800516. doi: 10.2807/1560-
7917.ES.2018.23.46.1800516.
15. Magill SS, O’Leary E, Janelle SJ, et al. Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals. N Engl J Med. 2018;379(18):1732-1744. doi: 10.1056/NEJMoa1801550
16. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-
46. doi: 10.1001/jamainternmed.2013.9763
17. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related
mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2):101-14. doi: 10.1086/657912.
18. Langmuir AD. The surveillance of communicable diseases of national importance. N Engl J Med. 1963;268:182-92. doi: 10.1056/NEJM196301242680405.
19. Mwanja H, Waswa JP, Kiggundu R, et al. Utility of syndromic surveillance for the surveillance of healthcare-associated infections in resource-limited settings: a narrative review. Front Mic-
robiol. 2024 Oct 21;15:1493511. doi: 10.3389/fmicb.2024.1493511
20. Gani I, Litchfield I, Shukla D, Delanerolle G, Cockburn N, Pathmanathan A.
Understanding “Alert Fatigue” in Primary Care: Qualitative Systematic Review of General Practitioners Attitudes and Experiences of Clinical Alerts, Prompts, and Reminders
J Med Internet Res 2025;27:e62763. doi: 10.2196/62763
21. CDC NHSN (National Healthcare Safety Network). Ventilator-Associated Event (VAE), 2025 https://www.cdc.gov/nhsn/pdfs/pscmanual/10-vae_final.pdf (erişim tarihi, 30 Ekim 2025)
22. Nascimento GM, Rodrigues DLG, Piastrelli FT, et al. Ventilator-associated events criteria in the assessment of Ventilator-Associated Pneumonia (IMPACTO MR-PAV): A prospective cohort.
Braz J Infect Dis. 2025;29(4):104543. doi: 10.1016/j.bjid.2025.104543
23. Barbut F, Mostaghat I, Ehmig M, Roukoz-Diab Y, Couturier J. Laboratory diagnosis of Clostridioides difficile infection: past, present and future. Anaerobe. 2025;93:102974. doi: 10.1016/j.
anaerobe.2025.102974
24. Ling ML, Apisarnthanarak A, Madriaga G. The burden of healthcare-associated infections in Southeast Asia: a systematic literature review and meta-analysis. Clin Infect Dis. 2015;60(11):1690-
9. doi: 10.1093/cid/civ095.
25. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Ulusal Sağlık Hizmeti İle İlişkili Enfeksiyonlar Sürveyans Standartları, 2024. https://hsgm.saglik.gov.tr/depo/birimler/bulasici-hastalik-
lar-ve-erken-uyari-db/Dokumanlar/ Rehberler/ Ulusal_Saglik_Hizmeti_ile_Iliskili_Efeksiyonlar_Surveyans_Standartlari_2024.pdf (erişim tarihi, 2 Kasım 2025)
26. Madran B, Genç Z, Keske Ş, et al. Healthcare-Associated Infection Rates in Türkiye (2014-2023): A Systematic Review and Meta-Analysis. Infect Dis Clin Microbiol. 2025 ;7(1):17-26. doi:
10.36519/idcm.2025.47
27. Salge TO, Vera A, Antons D, Cimiotti JP. Fighting MRSA Infections in Hospital Care: How Organizational Factors Matter. Health Serv Res. 2017;52(3):959-983. doi: 10.1111/1475-6773.12521
28. Wood DM, Beauvais B, Sturdivant RX, Kim FS. Evaluating the Effect of Financial Penalty on Hospital-Acquired Infections. Risk Manag Healthc Policy. 2024;17:2181-2190. doi: 10.2147/
RMHP.S469424
29. Gastaldi S, Accorgi D, D’Ancona F. Tools and strategies for monitoring hospital environmental hygiene services. J Hosp Infect. 2025 ;159:52-61. doi: 10.1016/j.jhin.2025.01.011
30. Santella B, Donato A, Fortino L, et al. Clean to Prevent, Monitor to Protect: A Scoping Review on Strategies for Monitoring Cleaning in Hospitals to Prevent HAIs. Infect Dis Rep. 2025
;17(5):120. doi: 10.3390/idr17050120
31. Cozzolino C, Mao S, Bassan F, et al. Are AI-based surveillance systems for healthcare-associated infections ready for clinical practice? A systematic review and meta-analysis. Artif Intell Med.
2025 ;165:103137. doi: 10.1016/j.artmed.2025.103137
32. Sheikh A, Anderson M, Albala S,et al. Health information technology and digital innovation for national learning health and care systems. Lancet Digit Health. 2021;3(6):e383-e396. doi:
10.1016/S2589-7500(21)00005-4
33. van Mourik MSM, Perencevich EN, Gastmeier P, Bonten MJM. Designing Surveillance of Healthcare-Associated Infections in the Era of Automation and Reporting Mandates. Clin Infect Dis.
2018 ;66(6):970-976. doi: 10.1093/cid/cix835
34. El Arab RA, Almoosa Z, Alkhunaizi M, Abuadas FH, Somerville J. Artificial intelligence in hospital infection prevention: an integrative review. Front Public Health. 2025 Apr 2;13:1547450.
doi: 10.3389/fpubh.2025.1547450
35. Odoom A, Tetteh-Quarcoo PB, Donkor ES. Prevalence of Hospital-Acquired Infections in Low- and Middle-Income Countries: Systematic Review and Meta-Analysis. Asia Pac J Public
Health. 2025;37(5):448-466. doi: 10.1177/10105395251338002
36. Takaya S, Hayakawa K, Matsunaga N, et al. Surveillance systems for healthcare-associated infection in high and upper-middle income countries: a scoping review. J Infect Chemother.
2020;26(5):429-37. doi: 10.1016/j.jiac.2020.01.001.
37. Rosenthal VD, Yin R, Nercelles P, et al. International Nosocomial Infection Control Consortium (INICC) report of health care associated infections, data summary of 45 countries for 2015
to 2020, adult and pediatric units, device-associated module. Am J Infect Control. 2024 ;52(9):1002-1011. doi: 10.1016/j.ajic.2023.12.019
38. Westercamp MD, Dudeck MA, Allen-Bridson K, et al. Performance of simplified surgical site infection (SSI) surveillance case definitions for resource limited settings: Comparison to SSI cases
reported to the National Healthcare Safety Network, 2013-2017. Infect Control Hosp Epidemiol. 2020 ;41(5):611-613. doi: 10.1017/ice.2020.36.
39. WHO. Global Antimicrobial Resistance and Use Surveillance System (GLASS). https://www.who.int/initiatives/glass (erişim tarihi, 27 Ekim 2025)
40. Fuller RL, Hughes JS, Atkinson G, Aubry BS. Problematic Risk Adjustment in National Healthcare Safety Network Measures. Am J Med Qual. 2020;35(3):205-212. doi: 10.1177/1062860619859073
41. Baker MA, Yokoe DS, Stelling J, et al. Automated outbreak detection of hospital-associated pathogens: Value to infection prevention programs. Infect Control Hosp Epidemiol. 2020
;41(9):1016-1021. doi: 10.1017/ice.2020.233
42. Ingelbeen B, van Kleef E, Mbala P, et al. Embedding risk monitoring in infectious disease surveillance for timely and effective outbreak prevention and control. BMJ Glob Health. 2025
;10(2):e016870. doi: 10.1136/bmjgh-2024-016870
43. Jang Y, Lee H, Park H. Surveillance System for Infectious Disease Prevention and Management: Direction of Korea’s Infectious Disease Surveillance System. J Korean Med Sci. 2025 ;40(8):e108.
doi: 10.3346/jkms.2025.40.e108
44. ECDC Surveillance Report. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2022–2023;2024 https://www.ecdc.europa.eu/
sites/default/files/documents/healthcare-associated-point-prevalence-survey-acute-care-hospitals-2022-2023.pdf (erişim tarihi, 25 Eylül 2025)
45. NICE-National Institute for Health and Care Excellence.2016. Healthcare-associated infections https://www.nice.org.uk/guidance/qs113/resources/healthcareassociated-infecti-
ons-pdf-75545296430533 (erişim tarihi, 2 Kasım 2025)
46. The Canadian Nosocomial Infection Surveillance Program: Keeping an eye on antimicrobial resistance in Canadian hospitals since 1995. Can Commun Dis Rep. 2022 Nov 3;48(11-12):506-
511. doi: 10.14745/ccdr.v48i1112a03
47. Cimen C, Berends MS, Lokate M, et al. Infection prevention and control without borders: comparison of guidelines on multidrug-resistant organisms in the northern Dutch-German
cross-border region. Antimicrob Resist Infect Control. 2025 ;14(1):11. doi: 10.1186/s13756-025-01528-3
48. TC Sağlık Bakanlığı. Halk Sağlığı Genel Müdürlüğü Bulaşıcı Hastalıklar ve Erken Uyarı Dairesi Başkanlığı. Ulusal Sağlık Hizmeti İlişkili Enfeksiyonlar Sürveyans Ağı (USHIESA) Özet Ra-
poru 2024 https://hsgm.saglik.gov.tr/media/attachments/2025/06/23/ek_ulusal-saglik-hizmeti-ile-Iliskili-enfeksiyonlar-surveyans-agi-ushIesa-Ozet-raporu-2024.pdf, (erişim tarihi, 30 Ekim
2025)
49. Meckawy R, Stuckler D, Mehta A, Al-Ahdal T, Doebbeling BN. Effectiveness of early warning systems in the detection of infectious diseases outbreaks: a systematic review. BMC Public Health.
2022 ;22(1):2216. doi: 10.1186/s12889-022-14625-4